The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling th...
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...
Singapore: Two approved drugs, an antifungal and a steroid, may potentially take on new roles as treatments for multiple...
Singapore: A group of researchers from Institute of Bioengineering and Nanotechnology (IBN) is using green tea ingredien...
Singapore: Singapore and Scotland based TauRx Pharmaceuticals, a clinical-stage biopharmaceutical company developing a n...
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...
Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innov...
Singapore: Sinovac Biotech, a leading China-based vaccine manufacturer, has been selected by the Jiangsu Centers for Dis...
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...
Singapore: Pfizer's high hopes for its JAK3 (Janus kinase) inhibitor, tofacitinib (tasocitinib, CP-690550), now branded ...
Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...
Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...
Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...
Singapore: Novartis has partnered with Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tube...
